Pliant Therapeutics, Inc.
PLRX· Nasdaq
Released Aug 11, 2020, after the close
10-Q filed Aug 11, 2020, 42 days after period end · 0001564590-20-039327
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Revenue | $3.60M | — |
| Net Income | -$17.00M | -$15.52M |
| EPS Diluted | -$1.39 | -$10.82 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pliant Therapeutics, Inc. · CIK 1746473 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2020 · filed Aug 11, 2020 · 42 d after period end
8.2% from the close of Aug 11, 2020 to the close of Aug 12, 2020, the first after the release.